Key terms

About PBYI

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest PBYI news

Mar 20 8:37am ET FDA allows Puma to proceed under IND with alisertib development for BC by TipRanks Mar 19 10:17pm ET Puma Biotechnology says court denied AstraZeneca’s motion for invalidity by TipRanks Mar 01 8:37am ET Buy Rating on Puma Biotechnology Amid Financial Challenges and Drug Advancement Prospects by TipRanks Mar 01 8:25am ET Puma Biotechnology price target lowered to $7 from $8 at H.C. Wainwright by TipRanks Mar 01 3:00am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Jazz Pharmaceuticals (JAZZ), Puma Biotechnology (PBYI) and MoonLake Immunotherapeutics (MLTX) by TipRanks Feb 29 11:05pm ET Puma Biotechnology: Hold Rating Justified by Underwhelming Sales and Limited Growth Outlook by TipRanks Feb 29 4:19pm ET Puma Biotechnology sees Fy24 revenue $214M-$225M, consensus $244.7M by TipRanks Feb 29 4:18pm ET Puma Biotechnology sees Q1 revenue $40.5M-$43M, one estimate 56.5M by TipRanks Feb 29 4:18pm ET Puma Biotechnology reports Q4 EPS 31c, consensus 30c by TipRanks Feb 13 11:10am ET Analysts Are Bullish on Top Healthcare Stocks: Puma Biotechnology (PBYI), ESSA Pharma (EPIX) by TipRanks Jan 19 11:24am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Jan 18 11:32am ET Biotech Alert: Searches spiking for these stocks today by TipRanks

No recent news articles are available for PBYI

No recent press releases are available for PBYI

PBYI Financials

1-year income & revenue

Key terms

PBYI Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

PBYI Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel
JPMorgan beat earnings expectations this Friday, unofficially kicking off the first quarter earnings season.
Win McNamee/Getty Images
Jamie Dimon says chance of a bad economy is ‘higher than other people think’